MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

“…</b> Relative expression of miR-129-5p in the control and CRS groups. <b>M.</b> Relative expression of miR-129-5p in the CTX, HIP, and HB of control and CRS mice. …”

Additional tryptophan metabolite alterations in response to a control diet or a diet containing MCOA: a. by Natalie E. Diether (16705804)

Serial MRE and PDFF at each time point in responders and non-responders. by Natthaya Chuaypen (6726911)

Chimera and wild-type virus replication at early time points. by Anja vom Hemdt (19787189)

Measured glucose concentration at time points 1, 5, 10 min, and 4h in 100 <i>μ</i>L incubations. by Hamidreza Arjmandi (19657263)

Survey periods in connection with the number of new infections and key points of the regulatory orders in Germany. by Julie Levacher (14485531)

nanoDSF apparent melting points. by Aleksi Sutinen (10039145)

Flagella-mediated motility affected by <i>bipA</i> deletion in <i>S</i>. Typhimurium. by Eunsil Choi (8271039)

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Cellular uptake of [¹⁴C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

Viability of SARS-CoV-2 on stainless steel after exposure to simulated sunlight. by Angela Sloan (380916)

A37 increases the M1 protein stability and viral pathogenicity of H5N6 virus. by Chenxi Wang (284364)

Dose response of airways to Methacholine shows a decreased contractility in <i>GSTCD</i>^-/- mouse lungs following LPS treatment. by Bo Liu (127343)

E₅₀ values of angle. by Junxia Zhou (14381598)

Curve fitting of E₅₀. by Junxia Zhou (14381598)

Fitting curves of E₅₀. by Junxia Zhou (14381598)

E₅₀ values of size. by Junxia Zhou (14381598)

E₅₀ fluctuation coefficient. by Junxia Zhou (14381598)

Fitting relationship of E₅₀. by Junxia Zhou (14381598)